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Current modeling of infectious diseases allows for the study of complex and realistic scenarios that go from
the population to the individual level of description. However, most epidemic models assume that the spreading
process takes place on a single level (be it a single population, a meta-population system or a network of con-
tacts). In particular, interdependent contagion phenomena can only be addressed if we go beyond the scheme
one pathogen-one network. In this paper, we propose a framework that allows describing the spreading dynam-
ics of two concurrent diseases. Specifically, we characterize analytically the epidemic thresholds of the two
diseases for different scenarios and also compute the temporal evolution characterizing the unfolding dynam-
ics. Results show that there are regions of the parameter space in which the onset of a disease’s outbreak is
conditioned to the prevalence levels of the other disease. Moreover, we show, for the SIS scheme, that under
certain circumstances, finite and not vanishing epidemic thresholds are found even at the thermodynamic limit
for scale-free networks. For the SIR scenario, the phenomenology is richer and additional interdependencies
show up. We also find that the secondary thresholds for the SIS and SIR models are different, which results
directly from the interaction between both diseases. Our work thus solve an important problem and pave the
way towards a more comprehensive description of the dynamics of interacting diseases.
PACS numbers: 87.23.Ge, 89.20.-a, 89.75.Fb
ar
X
iv
:1
40
2.
45
23
v2
  [
ph
ys
ics
.so
c-p
h]
  3
0 J
ul 
20
14
2I. INTRODUCTION
The problem of how diseases spread has been studied for a long time [1–8]. In the last few years, due to the increasing
availability of data about transmission patterns, contact networks and population mobility, it has become apparent that we are in
the position to develop theoretical and computational frameworks that will ultimately allow the forecast of epidemic outbreaks
[9–26]. The latter is a consequence of the increasing availability of new models that are capable of providing better predictions of
real epidemic scenarios [27]. In particular, we have been able to identify what ingredients are key to characterize the unfolding
of a disease outbreak. This is the case of the structure of the population in the form of networks of contacts at a local scale
[9, 17, 19, 28], or of individual mobility patterns that facilitate the spreading of diseases in wider geographical areas [29]. The
theoretical implications of considering these aspects have been thoroughly addressed [30–33], and at the same time, the amount
and quality of real data that are relevant to epidemic spreading is constantly increasing [34, 35].
In this context, an emergent field of research is the modeling of coupled spreading phenomena, whether they are two pathogens
or multiple strains of the same disease that propagate concurrently on the same population [33, 36–39]. Focusing on the two-
pathogen scenario, the complexity of the problem increases because now the natural history of one of the diseases is affected
by the presence of the second one, typically as a consequence of the modification of the host’s immune response after infection
− with a plethora of possibilities as given by different interaction schemes −. In addition, the networks of contacts through
which the pathogens spread can vary from one disease to the other. Typical examples of these coupled spreading phenomena are
given by the interaction between HIV infection and the spreading of certain opportunist pathogens [40, 41], or the strain-strain
interactions of a viral pathogen like the flu virus [43].
From a theoretical point of view, one of the first works that considered the above problem from a networked point of view
is due to Funk and Jensen in 2010 [37]. In their work, the authors exploited the analogy of the spreading process with a bond-
percolation problem so as to address the issue of epidemic thresholds in a SIR (Susceptible-Infected-Removed) model. However,
this first work did not consider a framework in which the temporal evolution of the epidemics can be studied. Following a similar
bond-percolation approach Mills et al. [44], motivated by the interaction between AIDS and Tuberculosis, studied two coupled
SIR models where the diseases can spread in both layers at different rates. Also in this case, due to the static nature of the
bond-percolation approach, the temporal evolution of the diseases cannot be studied. Recently, Marceau et al. presented a new
model [39] aimed at studying the latter aspect, also in within SIR scheme, using “on-the-fly graphs”, a network generation
model previously introduced by the authors [45]. In this work, although the temporal evolution of the system can be monitored,
the modeling approach does not provide information about epidemic thresholds. In addition, the model can not be trivially
generalized so as to cover other classical models like SIS (Susceptible-Infected-Susceptible). Other works have considered the
problem by studying the spreading of the diseases as a Markovian process. In [46] the authors, using two coupled Markov
processes, studied the competition of two epidemics and found different regions of the parameters space where the two diseases
can coexist. However, the model in [46] only represents the specific scenario of two mutually excluding diseases. It is also worth
mentioning that using a similar approach, the so-called microscopic Markov-Chain [25], the specific case in which a disease and
an ”awareness” diffusion process coexist has been studied in [47].
In this work, we propose a modeling framework, based on an heterogeneous mean field (HMF) approximation, for the spread-
ing of two concurrent diseases that interact with each other. To this purpose, we analyze in detail the dynamics of a two-layer
system that represents the networks of contacts on top of which either two coupled SIS or SIR processes spread. Although
we use as a convenient representation of the system under study a topology that has attracted a lot of attention lately, i.e., the
so-called multilayer networks [48, 49], we stress that the main focus is to study what are the effects of the complex interplay
between the different interaction mechanisms considered and the temporal and topological scales onto the dynamical behavior
of the diseases. Specifically, we explicitly derive the epidemic threshold of each disease in terms of the parameters that char-
acterize their evolution and the topology of the networks of contacts. Remarkably, we find that the epidemic thresholds in the
SIR case are different from those of the SIS case, which is a consequence of the emergence of new mechanisms of interaction
and to the transitory nature of the epidemic outbreaks in the SIR case. Additionally, different scenarios and limiting cases of
both theoretical and epidemiological interest are scrutinized. Finally, results from numerical simulations are presented to val-
idate our analytical results. Our work thus shows how the different interaction mechanisms considered can give rise to new
phenomenological insights regarding the dynamics of interacting diseases.
II. MODELING FRAMEWORK
Our purpose in this work is to explore epidemiological scenarios in which two different infectious diseases simultaneously
spread through the same host population, and whose dynamical parameters (i.e. infectiousnesses and recovery rates) depend,
at the level of single individuals, on whether the agents involved have caught only one of the diseases or both. In addition, we
consider that neither the mechanisms behind each disease evolution nor the contact networks through which they spread have to
be the same, and thus, are considered independently for each disease. Let us then consider that we have two diseases (disease
1 and disease 2) which spread over two different networks of contacts: disease 1 propagates over network 1, which has a mean
3FIG. 1: (color online) SIS-SIS interacting diseases model (a) Each of the diseases spreads over a different network. Each individual belongs
simultaneously to each network and can be (or not) infected with each of the diseases. (b) Set of transitions allowed in the model. The variables
(SS(k, l), IS(k, l), SI(k, l), II(k, l)) represent the densities of individuals of each type in the system having k neighbors in network 1 and l
neighbors in network 2.
degree 〈k〉 = ∑k,l P (k, l)k; whilst disease 2 does so over network 2, whose mean connectivity is equal to 〈l〉 = ∑k,l P (k, l)l.
The composed degree distribution P (k, l) gives the proportion of nodes (individuals) having k and l links in networks 1 and 2,
respectively [50]. In what follows, we consider independently both the SIS and SIR schemes.
A. The SIS scenario
As a first step, we will consider the baseline scenario in which the isolated dynamics of each disease, when the second is absent,
is described by a simple S-I-S scheme. Each individual belonging to a composed connectivity class (k, l) can be in four different
dynamical states: susceptible with respect to both diseases SS(k, l), infected of both II(k, l), and infected with the first (second)
one and still susceptible to catch the second (first) disease, IS(k, l) (SI(k, l)), being these quantities the proportion of individuals
at each disease state with composed degree class (k, l). Thus, we have that SS(k, l)+IS(k, l)+SI(k, l)+II(k, l) = 1 ∀(k, l).
In addition, regardless of the connectivities of the nodes involved, we have eight possible contagion transitions after a contact
(four for each disease). On the other hand, four other possible transitions correspond to the cases in which infected individuals
go back to the susceptible class. This amounts to a total of twelve elementary transitions, schematized as follows (see also
Figure. 1):
IS + SS
λ1−→ IS + IS
IS + SI
βa1λ1−−−→ IS + II
II + SS
βb1λ1−−−→ II + IS
II + SI
βa1β
b
1λ1−−−−−→ II + II
SI + SS
λ2−→ SI + SI
SI + IS
βa2λ2−−−→ SI + II
II + SS
βb2λ2−−−→ II + SI
II + IS
βa2β
b
2λ2−−−−−→ II + II
IS
µ1−→ SS
SI
µ2−→ SS
II
η1µ1−−−→ SI
II
η2µ2−−−→ IS
The model thus contains two basic infection probabilities –λ1 and λ2– as well as two basic recovery rates –µ1 and µ2–, one
for each disease. In addition, infection probabilities are affected by scaling factors –the four β’s and combinations of them–
4Parameter Dynamical meaning
λ1 Baseline infectiousness of disease 1
λ2 Baseline infectiousness of disease 2
µ1 Baseline recovery rate of disease 1
µ2 Baseline recovery rate of disease 2
βa1 Variation of disease 1 infectiousness due to the fact that the suscepti-
ble individual exposed to disease 1 is infected with disease 2
βa2 Variation of disease 2 infectiousness due to the fact that the suscepti-
ble individual exposed to disease 2 is infected with disease 1
βb1 Variation of disease 1 infectiousness due to the fact that the spreader
is also infected with disease 2
βb2 Variation of disease 2 infectiousness due to the fact that the spreader
is also infected with disease 1
η1 Variation of disease 1 recovery rate for individuals also infected with
disease 2
η2 Variation of disease 2 recovery rate for individuals also infected with
disease 1
TABLE I: Definition of model parameters
θIS1 =
∑
k,l P (k,l)kIS(k,l)∑
k,l P (k,l)k
probability that a given link of network 1 points to an IS node
θII1 =
∑
k,l P (k,l)kII(k,l)∑
k,l P (k,l)k
probability that a given link of network 1 points to an II node
θSI2 =
∑
k,l P (k,l)lSI(k,l)∑
k,l P (k,l)l
probability that a given link of network 2 points to a SI node
θII2 =
∑
k,l P (k,l)lII(k,l)∑
k,l P (k,l)l
probability that a given link of network 2 points to an II node
TABLE II: Definition of parameters θ.
and so are the recovery rates –by the η’s–, as it is explained in detail in Table I. These parameters describe the interaction
of the diseases through three different effects that are concurrently taken into account. The first effect is the variation of the
susceptibility of healthy individuals to get infected with one disease as a consequence of being infected with another. This
mechanism is described by βa1 for the variation of the infection risk of disease 1 caused by disease 2, and β
a
2 , for the symmetric
case. The second effect is the change of the spreading capabilities of double-infected individuals with respect to single-infected
ones, which is described by the parameters βb1 and β
b
2, for diseases 1 and 2, respectively. The last effect is the variation of the
infectious periods of double-infected individuals also with respect to single-infected ones, described by η1 and η2.
Therefore, these parameters exhaustively describe all the ways in which two diseases can interact according to a SIS scheme,
and allow us to isolate the different effects of one disease on the spreading of the other by making infectious individuals more
efficient spreaders or by making susceptible individuals more prone to get sick. Once we have defined the whole set of parameters
in table I, we have all possible transitions between dynamical states well defined (see Figure 1).
According to the scheme depicted in the figure (in which simultaneous double contagions and recoveries from both diseases
have been explicitly excluded), we can consider that all individuals within the same composed connectivity class (k, l) are
dynamically equivalent, in order to get a composed HMF for the dynamical description of both diseases which neglects, as a
first approximation, further correlations. In this way, the set of differential equations describing the evolution in time of the four
densities of individuals (SS(k, l), IS(k, l), SI(k, l), II(k, l)) is as follows:
˙SS(k, l) = −kλ1θIS1 SS(k, l)− lλ2θSI2 SS(k, l)− kβb1λ1θII1 SS(k, l)− lβb2λ2θII2 SS(k, l) + µ1IS(k, l) + µ2SI(k, l) (1)
˙IS(k, l) = kλ1θ
IS
1 SS(k, l) + kβ
b
1λ1θ
II
1 SS(k, l)− lβa2λ2θSI2 IS(k, l)− lβa2βb2λ2θII2 IS(k, l)− µ1IS(k, l) + η2µ2II(k, l) (2)
S˙I(k, l) = lλ2θ
SI
2 SS(k, l) + lβ
b
2λ2θ
II
2 SS(k, l)− kβa1λ1θIS1 SI(k, l)− kβa1βb1λ1θII1 SI(k, l)− µ2SI(k, l) + η1µ1II(k, l) (3)
˙II(k, l) = kβa1λ1θ
IS
1 SI(k, l) + lβ
a
2λ2θ
SI
2 IS(k, l) + kβ
a
1β
b
1λ1θ
II
1 SI(k, l) + lβ
a
2β
b
2λ2θ
II
2 IS(k, l)− (η1µ1 + η2µ2)II(k, l) (4)
where the θ parameters are defined in Table II.
5Prevalence
FIG. 2: (color online) Reciprocally enhanced spreading. Dynamical parameters: µ1 = µ2 = 0.75, βa1 = βb1 = βa2 = βb2 = 1.3, η1 =
η2 = 0.8. Networks: Erdo¨s-Renyi graphs: N1 = N2 = 5000 agents, 〈k〉 = 7, 〈l〉 = 8. The color maps represent the prevalence levels of
diseases 1 – upper panels – and 2 – lower panels –, at different stages of the Monte-Carlo simulations. Step 1 (panels a,d): stationary levels
after the initial introduction of an infection seed of disease 1 (IS = 0.005). Step 2 (panels b,e): once stage 1 is completed, an infection seed
of disease 2 (SI = 0.005) is introduced, and stationarity is recovered. Step 3: (panels c,f): after stage 2, an additional seed of infection 1
is re-introduced (IS = 0.005), and the stationary prevalences plotted. Dashed and solid lines represent respectively primary and secondary
thresholds predicted by the model.
Combining the probabilities θs and defining the following two new parameters σ1 = λ1(θIS1 + β
b
1θ
II
1 ) and σ2 = λ2(θ
SI
2 +
βb2θ
II
2 ) we obtain the average probabilities per link for SS-nodes to become infected with disease 1 (σ1) or disease 2 (σ2). This
allows us to rewrite the system of differential equations as:
˙SS(k, l) = −(kσ1 + lσ2)SS(k, l) + µ1IS(k, l) + µ2SI(k, l) (5)
˙IS(k, l) = kσ1SS(k, l)− lβa2σ2IS(k, l)− µ1IS(k, l) + η2µ2II(k, l) (6)
S˙I(k, l) = lσ2SS(k, l)− kβa1σ1SI(k, l)− µ2SI(k, l) + η1µ1II(k, l) (7)
˙II(k, l) = kβa1σ1SI(k, l) + lβ
a
2σ2IS(k, l)− (η1µ1 + η2µ2)II(k, l) (8)
Due to the closure relationship SS(k, l) + IS(k, l) + SI(k, l) + II(k, l) = 1 ∀(k, l), only three of these four equations are
linearly independent for each composed connectivity class (k, l). Taking this into account, we next analyze the time evolution
of the vector (IS(k, l), SI(k, l), II(k, l)), since SS(k, l) = 1− IS(k, l)− SI(k, l)− II(k, l).
1. Epidemic thresholds
In order to analyze the most relevant dynamical properties of the system, we look for the values
(IS∗(k, l), SI∗(k, l), II∗(k, l)) that define the stationary state: (I˙S∗(k, l), S˙I∗(k, l), I˙I∗(k, l)) = (0, 0, 0) ∀(k, l) for
the system Eq. (8). In order to do that, we are forced to consider σ1 and σ2 as additional parameters, although these two
quantities are linear combinations of the other variables and the ultimate responsible of the coupling among all connectivity
classes. As it happens commonly in this kind of models [6, 17], there exists a trivial fixed point of the dynamics in which there
are no infected individuals in the system: (II∗1 (k, l), II
∗
2 (k, l), II
∗(k, l)) = (0, 0, 0) ∀(k, l). This fixed point represents the
absorbing state of our model. In addition, there are other possible fixed points for which the densities of infected individuals
could be written as a function of the σ parameters: (II∗1 (k, l, σ1, σ2), II
∗
2 (k, l, σ1, σ2), II
∗(k, l, σ1, σ2)) 6= (0, 0, 0).
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FIG. 3: (color online) Reciprocally impaired spreading. Dynamical parameters: µ1 = µ2 = 0.75, βa1 = βb1 = βa2 = βb2 = 0.8, η1 = η2 =
1.3. Networks: Erdo¨s-Renyi graphs: N1 = N2 = 5000 agents, 〈k〉 = 7, 〈l〉 = 8. The color maps represent the prevalence levels of diseases 1
– upper panels – and 2 – lower panels –, at different stages of the Monte-Carlo simulations. As it is done in figure 2, we introduce successively
three infectious seeds (IS, SI, IS) = (0.005, 0.005, 0.005), and plot the stationary prevalences after each fluctuation in the three columns of
the figure. As it can be seen, the reintroduction of the third seed of infection 1 in the system does not affect the prevalence levels, as global
stability is reached after the second stage.
It is thus possible to get self-consistent equations for the variables σ as:
σ1 = f1(σ1, σ2) =
λ1
〈k〉
∑
k,l
P (k, l)k(IS(k, l, σ1, σ2) + β
b
1II(k, l, σ1, σ2)) (9)
σ2 = f2(σ1, σ2) =
λ2
〈l〉
∑
k,l
P (k, l)l(SI(k, l, σ1, σ2) + β
b
2II(k, l, σ1, σ2)) (10)
The condition σ1 = f1(σ1, σ2) > 0 implies the existence of a stable active state for the dynamics of disease 1, i.e., a state
in which disease 1 becomes endemic in the population. For this situation to take place for disease 2, the condition σ2 =
f2(σ1, σ2) > 0 must be fulfilled. Given the symmetry between the two expressions in Eq. (10), we will only focus on the
analysis of the first equation. In fact, it can be shown that always ∂
2f(σ1,σ2)
∂σ21
< 0, which means that, if we think of the graphical
solution of the equation σ1 = f1(σ1, σ2), for this non trivial solution to exist –given that, obviously f(σ1 = 0, σ2 = 0) = 0–
it must be verified that
[
∂f(σ1,σ2)
∂σ1
]
σ1=0
> 1, as in [17]. After some algebraic operations, this condition yields the following
expression:
λ1
∑
k,l P (k, l)k
2 l
2σ22β
a
2β
a
1β
b
1+lσ2(η2µ2β
a
1 +β
b
1(β
a
1µ1+β
a
2µ2))+µ2(η1µ1+η2µ2)
l2σ22β
a
2 η1+lσ2(η1µ1+η2µ2+β
a
2 η1µ2)+µ2(η1µ1+η2µ2)
µ1〈k〉 > 1 (11)
that allows us to derive the epidemic threshold as:
λc1(σ2) = µ1
〈k〉∑
k,l P (k, l)k
2 l
2σ22β
a
2β
a
1β
b
1+lσ2(η2µ2β
a
1 +β
b
1(β
a
1µ1+β
a
2µ2))+µ2(η1µ1+η2µ2)
l2σ22β
a
2 η1+lσ2(η1µ1+η2µ2+β
a
2 η1µ2)+µ2(η1µ1+η2µ2)
(12)
Looking at the latter expression −which contains the underlying topologies in a more intricate way than for the uncoupled,
classical case−, the threshold dependence on disease 2’s prevalence via σ2 becomes explicit. If we evaluate λc1(σ2 = 0) we
7recover the classical result λc1 = µ1〈k〉/〈k2〉 [9, 17]. Therefore, in the following we will refer to this baseline case as primary
threshold, λc1(0), whereas the more general case will be referred to as the secondary threshold, λ
c
1(σ2) (with σ2 > 0). Obviously,
the same stands for the primary (λc2(0)) and secondary thresholds (λ
c
2(σ1)) of the second disease.
A particular case for the topologies on top of which both diseases are spreading corresponds to the homogeneous mean field
version of the system, i.e., P (k, l) = δ(k − ko)δ(l − lo), for which the last expression can be rewritten as:
λc1 =
λ2lo
ko
η1µ1(β
a
2 (λ2lo − µ2) + µ1) + η2µ2µ1
µ2(η2µ2 + η1µ1) + (λ2lo − µ2)(βa2βa1βb1(λ2lo − µ2) + βa1βb1µ1 + η2µ2βa1 + βa2βb1µ2)
(13)
An independent derivation of this expression can be obtained by analyzing the Jacobian matrix of the homogeneous mean field
system analogous to Eq. (8) as it is shown in the Appendix A.
2. Phase diagrams
In order to explore the quality of the threshold prediction of our model, we have designed a Monte-Carlo simulation scheme
in which a single state transition is allowed per individual per time step. First, infected individuals will eventually spread the
disease(s) that they carry. As double events are not allowed at a single time step, forbidden double transitions from SS to II
are resolved by choosing the disease that an individual will catch proportionally to the status of her infected neighbors: the
more neighbors one individual has, say, carrying disease 1, the more likely she will become infected with disease 1 rather than
with disease 2. After the spreading loop is completed for both diseases, infected nodes who have not suffered any contagion
at the present time step eventually get back to the susceptible state of the disease(s) they carry. To avoid forbidden double
transitions from the II class to the SS class, in those cases the only disease the individual is going to recover from is also chosen
stochastically, according to the probabilities p1 = η1µ1/(η1µ1 + η2µ2) for the first disease, and p2 = 1− p1 for the second one.
Let us then explore first a simple scenario in which we assume that the dynamical effects of one disease on the other are totally
symmetric. In terms of the parameters of the model, this implies that βa1 = β
a
2 = β
b
1 = β
b
2 ≡ β and η1 = η2 ≡ η. In this case,
let’s focus on two opposite scenarios: i) mutual enhancement: η < 1 and β > 1 and ii) mutual impairment η > 1 and β < 1. In
the case of mutual enhancement, individuals who are infected with the second disease spread and become infected with disease
1 more easily than those who are not (this is because β > 1). In addition, since also η < 1, infected individuals of disease
1 remain so for longer times if they are also infected with the second disease. These two effects imply that the appearance of
disease 2 in the system enhances the spreading capabilities of disease 1. The reciprocal situation is also true, as the interaction
between both diseases is symmetric. Finally, in the case of mutual impairment, the effects on the infectiousness and recovery
rates are the opposite, and so the appearance of one of the diseases at a certain prevalence impairs the spreading of the other
disease. In Figures 2–3, we represent the prevalence of each disease, as a function of the baseline infectiousnesses (λ1, λ2) for a
given set of parameters after the introduction of infection seeds in the order shown. The networks through which diseases spread
are, for this first case, two uncorrelated Erdo¨s-Renyi graphs.
For the case of mutual enhancement (Fig. 2), given our set of parameters, the analytically-obtained curves for the secondary
threshold remain below the primary thresholds, leading to the appearance of two regions in the plane (λ1, λ2), for which it is
verified that λc1(σ2) < λ1 < λ
c
1(0) and λ
c
2(σ1) < λ2 < λ
c
2(0), respectively. The dynamical relevance of these regions is that
within them, the appearance of an outbreak of one of the diseases is conditional to the previous installation of the other infection
in the system. In this way we can observe that, after an initial seed of IS individuals, disease 1 does not become endemic in
the region λc1(σ2) < λ1 < λ
c
1(0) (fig. 2, panel a), but then, after the outbreak of the second disease in the network, the same
seed leads disease 1 to become endemic in that same region (fig. 2 panel C) as predicted by our model. Regarding the conjugate
region in which λc2(σ1) < λ2 < λ
c
2(0), we can see in figure 2, panel e, that disease 2 directly becomes endemic after the
introduction of an infection seed SI due to the fact that, previously, disease 1 was already introduced in the system.
The situation for the mutual impairment case is the opposite, and the secondary thresholds remain, in this case, above the
primary ones. So, in this scenario, we have another couple of relevant regions in which λc1(0) < λ1 < λ
c
1(σ2) and λ
c
2(0) <
λ2 < λ
c
2(σ1), respectively. In fig. 3, it is represented the behavior of the system under these conditions. In panel a, we can see
how disease 1 becomes endemic after the introduction of an initial seed above its primary threshold. Then, after introducing a
seed of disease 2, as shown in panel b for the area comprised between λc1(0) and λ
c
1(σ2), the prevalence of disease 1 vanishes.
In other words, in that region, the introduction of disease 2 makes it possible for the system to recover from disease 1. If we
look at the behavior of the second disease in the region in which λc2(0) < λ2 < λ
c
2(σ1), we see how the disease is unable to
become endemic as a consequence of the fact that the first disease has already been introduced in the system. This situation
suggests that, as it has already been addressed in the context of computational sciences [51], the introduction of an infectious
agent designed to immunize its host with respect to another, more harmful infection, might be a conceptually feasible option
to reduce the prevalence of the latter, or even to eradicate it. This has also been recently reported in the context of multi-strain
diseases, in which more than one strain of the same disease compete for the host population [33, 46].
Once the dynamics of the model has been exhaustively characterized when the diseases spread over homogeneous networks,
we move on and explore the influence of degree heterogeneity on the dynamics. To this end we also perform intensive numerical
8Prevalence
FIG. 4: (color online) Panels a and c: reciprocally enhanced spreading with βa1 = βb1 = βa2 = βb2 = 1.3, η1 = η2 = 0.8, represented at the
final stationary state. Panels b and d: reciprocally impaired spreading βa1 = βb1 = βa2 = βb2 = 0.8, η1 = η2 = 1.3, also at the final state.
Scale-free networks are generated using the uncorrelated configuration model with N1 = N2 = 5000 agents, 〈k〉 = 4.00, and 〈l〉 = 5.11.
The figure represents the final prevalence of diseases 1 (panels a and b) and 2 (panels c and d) in each case.
simulations in an analogous way, but using scale free graphs of the same size as before with different exponents. In Figure 4
we represent the final prevalence for each disease in two configurations: reciprocally enhanced diseases −panels a and c− and
impaired spreading−panels b and d−. In both cases, network 1 (γ = 2.7, panels a and b) has a greater power law exponent than
network 2 (γ = 2.5, panels c and d). As it can be seen, for both diseases and for both configurations, secondary thresholds are
closer to primary ones than in the case of homogeneous networks.
3. System sizes and epidemic thresholds: general case
In the previous sections we have described the baseline cases in which none of the dynamical parameters vanishes, and both
networks are, in each case, of the same kind –ER or uncorrelated SF graphs–. A relevant theoretical question yet remains
unanswered, i.e., how the epidemic thresholds behave when the system size grows and eventually reaches the thermodynamic
limit. Regarding this question, we present an exhaustive analysis in Appendix B, in which it is shown what are the conditions
that lead to have vanishing small secondary thresholds as a function of the underlying topologies and some of the dynamical
parameters − note, however, that this question is of interest from a theoretical viewpoint, as strictly speaking all real systems
are finite and thus an effective epidemic threshold exits. In addition, our approach is based on an HMF approximation, and that
means that influences of dynamical correlations on the analysis are neglected.
The results show that the secondary epidemic threshold associated to any of the diseases that is spreading over a scale-free
network with 2 < γ ≤ 3 vanishes at the thermodynamic limit, regardless of the topology of the network on top of which its
conjugate disease propagates and of the values of the dynamical parameters. In an analogously robust way, power laws with
γ > 3 −or homogeneous degree distributions− yield finite, non vanishing secondary thresholds at the thermodynamic limit,
regardless of the conjugate topologies or parameter values, with some exceptions.
The relevance of this result relies on the fact that the model predicts the same behavior for the epidemic thresholds in het-
erogeneous and homogeneous networks as compared with HMF models of uncoupled (single) diseases that spread over simple
networks. In addition, our analysis shows that the eventual vanishing of the epidemic thresholds for infinite systems is only
determined by the topology of the network under consideration rather than by any possible coupling with another disease that
spreads over any other possible conjugate network within our model framework. However, there is an exception to this general
behavior which is meaningful from an epidemiological viewpoint. This is the case when both diseases spread over two highly
and positively correlated scale-free networks with composed degree distribution P (k, l) = δ(k − l)αk−γ , where δ stands for
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FIG. 5: (color online) Primary and Secondary threshold values as a function of the size of the systemsN for different values of Θ: 0.0 (primary
threshold), 0.2, 0.4, 0.6, 0.8 and 1.0. Networks are uncorrelated scale free graphs (panel a) without correlations between them –panel a– or
with them –panel b, fully correlated–. Diseases interact according to a full cross-immunity scheme β1a = β2a = 0 and γ = Γ = 2.5. The rest
of the parameters are the same as in figure 2.
the Kronecker δ-function and α is a normalization constant. In that situation, if we focus, for example, in disease 1, there exist
two different interaction schemes of interest for which we recover finite epidemic thresholds λc1 > 0 at the thermodynamic limit
even for scale-free graphs with 2 < γ ≤ 3:
• Case 1: Individuals infected with disease 2 become immune to infection by disease 1. βa1 = 0 ; (βa2 , βb2, βb2) are free
parameters.
• Case 2: If βa1 6= 0, individuals infected with both diseases can not cause contagion of disease 1: βb1 = 0. In addition,
disease 1 can not cause total immunity to disease 2: βa2 6= 0. βb2 is a free parameter.
To illustrate this situation, we take as an example a particular case of the first scheme, a mutual cross-immunity scenario given
by βa1 = β
a
2 = 0. In order to point out the role of inter-layer degree correlations on this effect, we can directly compare the ex-
pression for the threshold when both networks are totally correlated with the analogous expression derived from an uncorrelated
combined degree distribution:
P (k, l) = δ(k − l)αk−γ → λc1(σ2) = µ1
〈k〉∑
k α
1
k2−γ
µ2
kσ2+µ2
(14)
P (k, l) = αk−γ l−Γ → λc1(σ2) = µ1
〈k〉∑
k,l α
1
k2−γ
1
lΓ
µ2
lσ2+µ2
(15)
In Figure 5, we represent the values predicted by these expressions for different network sizes, when γ = Γ = 2.5. As we
can see in panel a, for uncorrelated networks, regardless of the value of σ2, the threshold continuously decreases as we increase
network sizes. The result thus shows that the existence of a coupling with another disease present in the system with a certain
prevalence proportional to σ2, does not play any role, since the degree heterogeneities are still the main reason leading to the
vanishing of the threshold at the thermodynamic limit. This picture turns out to be remarkably different when we introduce
positive, strong correlations between the two networks. In that case, as we can see in panel b, the appearance of the second
disease, characterized by a certain prevalence level σ2 > 0, implies a sudden change in the behavior of the threshold, that does
not vanish anymore, even when N →∞.
The influence of degree correlations between networks for this case of full cross-immunity becomes evident also at finite
sizes, since the differences between primary and secondary thresholds, as seen in Fig. 6, are also greatly amplified. Another
eventually relevant effect that can be observed in the last figure is that the transition that takes place at the epidemic threshold
is much sharper in the case of correlated networks. All the previous results point out that the worst scenario for the spreading
10
Prevalence
FIG. 6: (color online) Effect of degree correlations between the two scale-free networks on the steady prevalence levels. Dynamical parameters:
µ1 = µ2 = 0.75, βa1 = βa2 = 0. The rest of parameters are irrelevant, as no II individual will appear in the system. Panels a and c: final
prevalence of diseases 1 and 2, respectively for uncorrelated scale-free networks: P (k, l) = P (k)P (l) = αk−γ l−γ . Panels b and d: final
prevalence of diseases 1 and 2, respectively for fully correlated scale-free networks: P (k, l) = αδ(k − l)k−γ . In both cases γ = 2.5.
of a disease when it interacts with a second one that confers immunity to the former corresponds to the case in which there is a
correlation between heterogeneous networks of contacts. This finding is essentially equivalent to what was found previously in
[37], what we have shown here is that the effect comes to revert the vanishing threshold at the thermodynamic limit for a disease
spreading on top of scale-free networks. In addition, we have found that it is not needed for this effect to take place that the
second disease confers full immunity to disease one.
Remarkably all these “pathological” cases can be identified without abandoning HMF descriptions. Beyond HMF, the behav-
ior of epidemic thresholds vary with respect to mean field predictions as a consequence of dynamical correlations [20, 53]. Here,
however, we identify that the interactions between diseases can modify the size scaling of thresholds from the classical mean
field picture without the need to recurring to dynamical correlations, which, for certain cases, remarkably modify the whole
picture at the thermodynamic limit, even in annealed networks in which adjacency matrices are only fixed on average, and so,
dynamical correlations do not exist.
B. The SIR scenario
In the previous sections we have studied the behavior of systems of interacting diseases that spread according to a SIS scheme,
thus leading, above the epidemic threshold, to stationary, endemic states with a prevalence greater than zero. In the following,
we will explore the case of transient, interacting epidemic phenomena.
In order to do so, we can extend the framework and describe the dynamics of two SIR epidemics interacting among them. In
classical, non-interacting systems –either homogeneous or heterogeneous–, the resemblance of both types of models translates
into a strong mathematical symmetry between them that yields identical expressions for the epidemic thresholds under mean
field descriptions (i.e. when neglecting the effects of dynamical correlations). In this section we will see the way in which part
of this symmetry is broken as a consequence of the interacting nature of the epidemic processes.
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New parameter Dynamical meaning
φa1 Variation of disease 1 infectiousness due to the fact that the suscep-
tible individual exposed to disease 1 has been infected and recovered
from disease 2
φa2 Variation of disease 2 infectiousness due to the fact that the suscep-
tible individual exposed to disease 2 has been infected and recovered
from disease 1
φb1 Variation of disease 1 infectiousness due to the fact that the spreader
has been infected and recovered from disease 2
φb2 Variation of disease 2 infectiousness due to the fact that the spreader
has been infected and recovered from disease 1
ζ1 Variation of disease 1 recovery rate for individuals that have been
infected and recovered from disease 2
ζ2 Variation of disease 2 recovery rate for individuals that have been
infected and recovered from disease 1
TABLE III: Parameters describing the influence of R classes on the conjugate infection
FIG. 7: (color online)Set of transitions allowed in the double SIR-SIR model. Yellow: contagion processes. Blue: recovery processes
1. Mathematical description
In this case, the first new aspect to note is that not just the condition of being infected with one disease can modify subjects’
susceptibility to the conjugate infection, but also whether they have been infected and recovered. For instance, this might
represent situations in which some kind of immunological memory is acquired after the first infection −for example, partial
immunity in front of other strains is gained after suffering an influenza infection, specially if both are phylogenetically close
enough [52]. This new phenomenology translates into the need of introducing new parameters (see Table III) describing new
eventual interactions and transitions, as shown in Fig 7. The system of equations describing the dynamics is now:
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˙SS(k, l) = −(kσ1 + lσ2)SS(k, l) (16)
˙IS(k, l) = kσ1SS(k, l)− βa2 lσ2IS(k, l)− µ1IS(k, l) (17)
S˙I(k, l) = lσ2SS(k, l)− βa1kσ1SI(k, l)− µ2SI(k, l) (18)
˙II(k, l) = βa1kσ1SI(k, l) + β
a
2 lσ2IS(k, l)− (η1µ1 + η2µ2)II(k, l) (19)
R˙S(k, l) = µ1IS(k, l)− φa2lσ2RS(k, l) (20)
˙SR(k, l) = µ2SI(k, l)− φa1kσ1SR(k, l) (21)
R˙I(k, l) = φa2lσ2RS(k, l) + η1µ1II(k, l)− ζ2µ2RI(k, l) (22)
˙IR(k, l) = φa1kσ1SR(k, l) + η2µ2II(k, l)− ζ1µ1IR(k, l) (23)
where all the parameters and variables that were present in the SIS formulation retain their original meaning, with the nuance
that now σ1 and σ2 have an extra term related to the appearance of classes IR and RI:
σ1 = λ1(θ
IS
1 + β
b
1θ
II
1 + φ
b
1θ
IR
1 ) (24)
σ2 = λ2(θ
SI
2 + β
b
2θ
II
2 + φ
b
2θ
RI
2 )
where θIR1 is the probability of a link of network 1 pointing to an IR node and θ
RI
2 is the probability of a link of network 2
pointing to a node in the RI state.
2. Epidemic thresholds
In order to characterize the epidemic threshold of disease 2, we need to study the dynamics of the system around any point
in which no infected individual of disease 2 has yet been introduced and so (SI(k, l), II(k, l), RI(k, l)) = (0, 0, 0)∀(k, l) as
well as θSI2 = θ
II
2 = θ
RI
2 = 0. Around such a disease free point -either fixed or not-, it is trivial to see that all the partial
derivatives of classes SI(k, l), II(k, l) and RI(k, l) with respect to the rest of dynamic classes vanish. This makes the subset of
variables {SI(k, l), II(k, l), RI(k, l)} locally autonomous around that point, and so, its linearization might serve us to address
the stability inversion yielding the emergence of the epidemic threshold.
In addition, the dimensionality of the system can be greatly reduced, if we write the equations driving the time evolution of
the probabilities θSI2 , θ
II
2 , and θ
RI
2 , as follows:
˙θSI2 =
∑
k,l P (k, l)lS˙I
〈l〉 =
〈l2SS〉
〈l〉 λ1(θ
SI
2 + β
b
2θ
II
2 + φ
b
2θ
RI
2 )− βa1
〈kl〉
〈l〉 θ
SI
2 λ1(θ
IS
1 + β
b
1θ
II
1 + φ
b
1θ
IR
1 )− µ2θSI2 (25)
˙θII2 =
∑
k,l P (k, l)l
˙II
〈l〉 =
〈kl〉
〈l〉 θ
SI
2 β
a
1λ1(θ
IS
1 + β
b
1θ
II
1 + φ
b
1θ
IR
1 ) +
〈l2IS〉
〈l〉 β
a
2λ2(θ
SI
2 + β
b
2θ
II
2 + φ
b
2θ
RI
2 )− (η1µ1 + η2µ2)θII2
˙θRI2 =
∑
k,l P (k, l)lR˙I
〈l〉 =
〈l2RS〉
〈l〉 φ
a
2λ2(θ
SI
2 + β
b
2θ
II
2 + φ
b
2θ
RI
2 ) + η1µ1θ
II
2 − ζ2µ2θRI2
where we have substituted 〈klSI〉 by 〈kl〉θSI2 , approximation which is valid around the point (SI(k, l), II(k, l), RI(k, l)) =
(0, 0, 0)∀(k, l). Obviously, as happened for {SI(k, l), II(k, l), RI(k, l)}, all of the partial derivatives of θSI2 , θII2 , and θRI2 with
respect to variables unrelated to θSI2 , θ
II
2 , and θ
RI
2 vanish, which allows us to study the stability of the system with respect to
disease 2 by linearizing the system: ( ˙θSI2 ,
˙θII2 ,
˙θRI2 ) = f(θ
SI
2 , θ
II
2 , θ
RI
2 ). The corresponding Jacobian matrix J can be calculated
this way, and, by evaluating the condition J = 0 for stability shift, the epidemic threshold takes its final value:
λc2(〈l2SS〉, 〈l2IS〉, 〈l2RS〉, σ1) =
(η2µ2 + η1µ1)(µ2〈l〉 + βa1σ1〈kl〉)ζ2µ2〈l〉
(η2µ2 + η1µ1)(ζ2µ2〈l〉〈l2SS〉 + φa2φb2〈l2RS〉(µ2〈l〉 + βa1 〈kl〉σ1)) + (βb2ζ2µ2 + φb2η1µ1)(βa1 〈kl〉σ1〈l2SS〉 + βa2 (µ2〈l〉 + βa1 〈kl〉σ1)〈l2IS〉)
(26)
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which depends on the initial prevalence of disease 1 via σ1, 〈l2IS〉, 〈l2RS〉 (and 〈l2SS〉). In the case of having non concurrent
outbreaks, we have that the second disease arrives to the system after the outbreak of the first disease has come to an end. In
that case, we have that IS(k, l) = 0 and RS(k, l) = R1∞,k,l ∀(k, l), where R1∞,k,l is the fraction of recovered individuals at the
end of an outbreak of disease one alone, in the composed degree class (k, l). In such a case, the problem is much simpler, as
σ1 = 〈l2IS〉 = 0, and 〈l2SS〉 = 〈l2〉 − 〈l2R1∞,k,l〉; and the threshold reads as:
λc2(〈l2〉, 〈l2R1∞,k,l〉) =
µ2〈l〉
〈l2〉+ (φa2φb2−ζ2)ζ2 〈l2R1∞,k,l〉
. (27)
Obviously, if disease 1 has not yet appeared in the system, the threshold for disease 2 becomes λc2 =
µ2〈l〉
〈l2〉 , as in the classical,
non interacting HMF case [19]. As done for the SIS model, we refer to the latter expression as the primary threshold of disease
2, in counterposition to the secondary threshold of Eq. (26).
A remarkable property of the threshold for the SIR scenario is that its dependence on the dynamical state of the conjugate dis-
ease is more complex than in the SIS case. Specifically, once an outbreak of one influencing infection is unfolding, the epidemic
thresholds of the other disease may vary with time in non trivial ways, depending on the nature and intensity of the different
interaction mechanisms present. Figure 8 shows results from numerical simulations illustrating the previous phenomenology
and the agreement with the analytical thresholds. Specifically, each panel represents the case in which the infection seed of the
second disease is introduced in different moments for each topology, coinciding with different stages of the outbreak of disease
1: early phases (panel a, SF and panel c, ER), outbreak’s peak (panel b, SF) and at the end of the outbreak (panel d, ER). As we
can see, regardless of the topology, the parameters’ values or the moment of appearance of the infection seed, our model ade-
quately foresees the epidemic threshold and its variations with time. As in the SIS case, the influence of the interactions on the
epidemic threshold is smaller in the case of scale free networks, due to the smaller values of the primary thresholds in that case
(in fact, primary thresholds have not been represented in panels a and b for the sake of clarity, because its values λ12c = 0.00316
virtually overlaps the secondary ones).
III. CONDITIONS FOR DISEASE ENHANCEMENT AND IMPAIRMENT
Finally, it is interesting to analyze what combinations of parameters give raise to situations in which there is either enhance-
ment or impairment of the diseases, as well as some other cases in which both effects are possible. This can be done for both the
SIS and the SIR scenarios by studying the sign of the difference between the primary and the secondary thresholds.
For the SIS case, if we focus, for example, on the second disease, we have:
λc2(σ1)− λc2(0) =
∑
k,l
C(k, l)σ1
[
βa1 (η2 − βa2βb2)kσ1 + (η2 − βa2βb2)µ2 +
(
η1(1− βa2 ) + βa1 (η2 − βb2)
)]
(28)
where C(k, l) is always positive. In this sense, λc2(σ1)− λc2(0) > 0 implies that disease 1 is reducing the epidemic threshold of
disease 2, thus enhancing its spreading. In the opposite case λc2(σ1) − λc2(0) < 0, disease 1 makes the secondary threshold for
disease 2 to be bigger than the primary one, hence impairing its spreading. As we can see, the condition yielding one or another
case involves a complex combination of the parameters. However, it is trivial to show that, provided that βa2 > 1, β
b
2 > 1 and
η2 < 1, disease 1 enhances disease 2 spreading for any value of σ1 greater than zero. We call this scenario coherent enhancement,
because all the interaction mechanisms contribute to enhance the spreading of disease 2. In a similar way, if βa2 < 1, β
b
2 < 1 and
η2 > 1, the interaction has the opposite sign regardless of σ1, and we have a situation of coherent impairment. Noticeably, if
none of these conditions is fulfilled, there exists the possibility that the sign of the influence that disease 1 exerts on the spreading
of disease 2 depends on its prevalence via σ1 (see below). In Fig. 9 we have represented λc2(σ1)− λc2(0) for different parameter
combinations that cover all possible phenomenologies.
For the SIR case, the proliferation of dynamical classes and the possibility that other mechanisms (i.e., those including R
individuals) carry the interaction between both disease makes the equivalent expression more complex, but still derivable as:
λc2(〈l2SS〉, 〈l2IS〉, 〈l2RS〉, σ1)− λc2(〈l2〉, 0, 0, 0) = (29)
C ′[µ2〈l〉(η1µ1 + η2µ2)
(
ζ2β
a
1σ1〈kl〉〈l2〉+ ζ2µ2〈l〉〈l2IS〉+ ((ζ2 − φa2φb2)µ2〈l〉 − βa1 〈kl〉σ1)〈l2RS〉
) −
−〈l〉µ2(φb2η1µ1 + βb2ζ2µ2)
(
βa1σ1〈kl〉〈l2SS〉+ βa2 (µ2〈l〉+ σ1〈kl〉)〈l2IS〉
)
]
where C ′ is always positive too.
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FIG. 8: (color online) Epidemic thresholds in the SIR-SIR interacting epidemic model. Upper panels: temporal evolution of dis-
ease 1, in a scale free (SF, left) and in an Erdos-Renyi network (ER, right): I1 =
∑
k,l P (k, l)(ISk,l + IIk,l + IRk,l)(t), R1 =∑
k,l P (k, l)(RSk,l +RIk,l +RRk,l)(t). Disease one enhances the spreading of disease two in both cases, but still is not influenced
by the second infection. Lower panels: total number of affected individuals by disease 2 as a function of λ2 in each network: R∞2 =
limt→∞
∑
k,l P (k, l)(SRk,l + IRk,l +RRk,l)(t). Dynamical parameters: panels a, b: scale free network: N = 5000, 〈k〉 = 4.00,〈l〉 =
5.11, λ1 = 0.02 µ1 = µ2 = 0.05, βa2 = βb2 = φa2 = φb2 = 1.3 η2 = ζ2 = 0.8 , panels c,d: Erdos-Renyi network: N = 5000,
〈k〉 = 7,〈l〉 = 8, λ1 = 0.02 µ1 = µ2 = 0.05, βa2 = βb2 = 3, φa2 = φb2 = 1.2, η2 = 0.33, ζ2 = 0.8. As said before, in both cases, disease 1 is
not influenced by disease 2, and so: βa1 = βb1 = φa1 = φa1 = η1 = ζ1 = 1.
As we have already said, in the interacting SIR model, once an outbreak of one disease has started, the temporal dependence of
the epidemic threshold of the second infection depends on the dynamic state of the system as well as on the parameter values that
account for the mechanisms of interaction that are present in the system and their intensities. In such a case, if the interaction
between the diseases is mediated by the class R, (i.e. being recovered of one disease is what makes subjects dynamics with
respect to the other infection to be altered, and so β and η parameters are equal to 1), the density of individuals belonging to
the R class is a monotonically increasing function of time. This trivially implies that, in general, the closer to its end is the
epidemic process for one disease, the deeper its impact on the conjugate one. However, if it is the I class the one that carries the
interaction, it is easy to see that that interaction will take place if and only if the outbreak of disease two happens within a time
window that -at least partially- overlaps with that characterizing the outbreak of disease 1. In such a situation, the interaction
between the two diseases is a transitory property of the system, and the shift in the epidemic threshold crucially depends on the
temporal co-occurrence of the outbreaks of both diseases.
A similar time-dependent shift of the epidemic thresholds can also take place in the SIS model, for example for the thresholds
of disease 2, if the difference λc2(σ1)−λc2(0) changes its sign during an outbreak of disease 1, as a consequence of the evolution
of σ1. This is the scenario given by the green and red curves in Fig. 9. However, it is worth remarking that such combinations
of parameters are somehow pathological, as they imply the appearance of diverse non-coherent mechanisms of interaction (i.e.
one disease simultaneously enhances subjects susceptibility to disease but, at the same time, it reduces their infectiousness, etc.)
that are epidemiologically less plausible. On the contrary, in the SIR framework, this transitoriness is an intrinsic property of the
system when the infected class is the responsible of influencing the dynamics of the conjugate disease. This transitory nature of
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FIG. 9: Relative variation of epidemic threshold of disease 2 as a function of σ1 for different parameter sets. Black: (coherent enhancement
of disease 1 over disease 2): λ1 = 0.2, µ1 = µ2 = 0.3, βa2 = βb2 = βa1 = βb1 = 1.1, η1 = η2 = 0.9. Blue: (coherent impairment of
disease 1 over disease 2): λ1 = 0.2, µ1 = µ2 = 0.3, βa2 = βb2 = βa1 = βb1 = 0.9, η1 = η2 = 1.1. Red: λ1 = 0.2, µ1 = 0.4, µ2 = 0.2,
βa2 = β
b
2 = 1.5, βa1 = 4, βb1 = 0.5, η1 = 0.4, η2 = 2. Green: λ1 = 0.2, µ1 = 0.4, µ2 = 0.2, βa2 = 0.5, βb2 = 1.5, βa1 = 4, βb1 = 0.5,
η1 = 0.4, η2 = 1. The networks are two Erdo¨s-Renyi graphs: N1 = N2 = 5000 agents, 〈k〉 = 7, 〈l〉 = 8.
the interactions constitutes an essential difference between the double SIR model with respect to the SIS one, which is at the root
of the remarkable difference between their corresponding thresholds and the richer phenomenology of two interacting SIR-like
processes.
IV. CONCLUSIONS
In this work, we propose a composed HMF model to describe the simultaneous spreading of two diseases over the same
population but driven by independent mechanisms of transmission taking place on different networks of contacts. Within this
framework, we have thoroughly studied extensions of the SIS and SIR models, where the parameters defining the infectious and
recovery transitions of one disease depend on the state of each node with respect to the conjugate disease, establishing in this
way a coupling between both diffusion processes. Our modeling approach presents different advantages with respect to previous
models [36–39], as it simultaneously allows analytical derivations of the epidemic thresholds and an approximate description
of the temporal evolution of the system, besides providing a way to isolate the effects on spreading dynamics of each possible
interaction mechanism, such as variations of infectivity, susceptibility or infectious periods. In addition, it enables us to solve
the two paradigmatic modeling scenarios (SIS and SIR), identifying relevant differences between the two cases that arise as a
consequence of disease interactions.
The model here presented and analyzed, even if it is based on an HMF and so, constitutes a first approximation to the problem
that neglects dynamical correlations among nodes, is able to identify novel phenomena qualitatively different to what is found
on HMF descriptions of non interacting systems. First, our model foresees different thresholds for SIR and SIS models, which
arises from the asymmetry between the interaction mechanisms that take place under both models. Additionally, in what regards
size scaling of epidemic thresholds, at least in the SIS case, we have identified some relevant situations that yield threshold
dependences on network’s size which are different from what is found in HMF models for single diseases. At this particular, it
is worth mentioning that asymmetries between SIS and SIR critical properties [20, 53], or a different behavior with respect to
that predicted by the HMF for epidemic thresholds [24] have also been identified in the context of single diseases spreading over
one network, if the HMF approach is abandoned.
The situation here is qualitatively different, as all these divergent results with respect to classical HMF models of single
diseases do not arise as a consequence of considering any dynamical correlation but as a consequence of disease-disease inter-
actions. This has two relevant implications. On the one hand, deviations from HMF results on epidemic thresholds on single
diseases identified as a consequence of considering dynamical correlations are of quantitatively residual relevance, precisely
because, at the epidemic threshold, those correlations tend to vanish and, there, HMF models perform consistently well [24].
Instead, in our case, differences between SIS and SIR thresholds, for example, are totally different, as they even may depend
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TABLE IV: Linear stability analysis of the fixed point (IS, SI, II) = (0, 0, 0)
Eigen-value Eigen-vector (IS, SI, II) Stability condition (epidemic threshold)
ξ1 = λ1ko − µ1 ~ψ1 = (1, 0, 0) λ1 < λc1i = µ1/ko
ξ2 = λ2lo − µ2 ~ψ2 = (0, 1, 0) λ2 < λc2i = µ2/lo
ξ3 = −(η1µ1 + η2µ2) ~ψ3 =
(
− η2µ2+βb1λ1ko
(λ1ko−µ1)+(η1µ1+η2µ2) ,−
η1µ1+β
b
2λ2lo
(λ2lo−µ2)+(η1µ1+η2µ2) , 1
)
always stable
on conceptually different interaction mechanisms. On the other hand, HMF is exact when dealing with annealed networks [20],
and so, on these type of networks which lack, by definition, dynamical correlations, both SIS-SIR asymmetries and eventually
anomalous threshold dependences with size that we have identified in this work constitute phenomena not found before.
In addition, for the first time, the modeling framework proposed here allows to isolate the independent effects of the different
mechanisms of interaction that can determine the critical properties of the model. On the one hand, this allows us to foresee that,
in a SIS model, certain interaction schemes may yield to effects of one disease on another of different sign as a function of the
prevalence levels of the former. On the other hand, for the SIR model, we have also discussed how the interaction between the
two diseases and the different dynamical classes give rise to a richer phenomenology. In particular, we have shown that due to
the transitory nature of SIR spreading processes, the moment at which the interaction of the two diseases is made effective might
greatly determine the values of the epidemic threshold of the disease whose course is modified by the other one.
Further advances in the field should address the influences of dynamical correlations between nodes on the spreading of inter-
acting epidemics. This constitutes a truly conceptual challenge as, for example, pairwise descriptions of the disease dynamics
[53], should transform into quadruplet-based descriptions, as, in this case, dynamical correlations go beyond the dynamical state
of neighbors in a network, but comprises both dynamical states on the two networks involved, which multiplies the complexity
of the description.
Appendix A: Epidemic thresholds on regular networks
In the particular case in which both networks are regular graphs, an independent derivation of the epidemic threshold can be
obtained by a linear stability analysis. In that case, for which P (k, l) = δ(k − ko)δ(l − lo), the dynamics can be described by
the following system of four equations:
˙SS = −koλ1SS · IS − loλ2SS · SI − koβb1λ1SSII − loβb2λ2SS · II + µ1IS + µ2SI,
˙IS = koλ1SS · IS + koβb1λ1SS · II − loβa2λ2SI · IS − loβa2βb2λ2IS · II − µ1IS + η2µ2II,
S˙I = loλ2SS · SI + loβb2λ2SS · II − koβa1λ1IS · SI − koβa1βb1λ1SI · II − µ2SI + η1µ1II,
˙II = koβ
a
1λ1IS · SI + loβa2λ2IS · SI + koβa1βb1λ1SI · II + loβa2βb2λ2IS · II − (η1µ1 + η2µ2)II,
one of which is linearly dependent of the rest. Thus, we will only analyze the system constituted by the three last equations and
use s = 1 − IS − SI − II . In order to perform a linear stability analysis we first linearize the system around the equilibrium
point and we calculate the Jacobian to get:
J =
∣∣∣∣∣∣∣
λ1ko − µ1 0 koβb1λ1 + η2µ2
0 λ2lo − µ2 loβb2λ2 + η1µ1
0 0 −(η1µ1 + η2µ2)
∣∣∣∣∣∣∣ (A1)
which, taking advantage of the fact that the Jacobian itself is just the product of the elements in the diagonal, yields the stability
conditions detailed in table IV.
If we look carefully at the results sketched in table IV, we firstly recognize the appearance of a couple of critical values for the
infectiousnesses λc1i and λ
c
2i which will be referred to in what follows as the primary thresholds of their respective diseases, just
like in the general case described in the main text. These threshold values stand for the minimum values of the infectiousnesses
that yield epidemic outbreaks after the introduction of infinitesimal seeds of infected individuals of each disease in an initially
healthy population. Therefore, the condition λ1 > λc1i must be verified in order to have an epidemic outbreak for the first
disease once an infinitesimal seed (IS, SI, II) = (, 0, 0) has been introduced on a system being at the disease-free fixed point
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(IS, SI, II) = (0, 0, 0). On the other hand, the condition λc2i plays an equivalent role for the second disease with respect to a
seed (IS, SI, II) = (0, , 0).
The fixed point (IS, SI, II) = (0, 0, 0) is, strictly speaking, not the only possible disease-free fixed point in our model.
Other two partially disease-free fixed points can exist: a first fixed point in which disease 1 is installed in the system at a certain
prevalence pi1 whilst disease 2 is absent (IS, SI, II) = (pi1, 0, 0) and its cognate (IS, SI, II) = (0, pi2, 0), for which there is
no individual infected with disease 1. As we are going to show, the stability of these fixed points depends on the prevalence
fractions pi1 and pi2, which are the stationary proportions of sick individuals of each disease:
pi1 =
λ1ko − µ1
λ1ko
(A2)
pi2 =
λ2lo − µ2
λ2lo
(A3)
Considering that, let us study the stability of the first fixed point (IS, SI, II) = (pi1 = λ1ko−µ1λ1ko , 0, 0) as a function of λ1: the
Jacobian, around this fixed point takes the following form:
J =
∣∣∣∣∣∣∣
(µ1 − λ1ko) (µ1 − λ1ko)(1 + βa2 λ2loλ1ko ) βb1λ1ko + η2µ2 + (µ1 − λ1ko)(βb1 + 1 + βa2βb2 λ2loλ1ko )
0 (λ2lo − µ2) + (µ1 − λ1ko)( λ2loλ1ko + βa1 ) βb2µ1 λ2loλ1ko + η1µ1
0 (λ1ko − µ1)(βa2 λ2loλ1ko + βa1 ) (λ1ko − µ1)βa2βb2 λ2loλ1ko − (η1µ1 + η2µ2)
∣∣∣∣∣∣∣ (A4)
By solving the equation derived from imposing that J = 0, we obtain the values of the parameters leading to stability
inversion. As it can be shown at naked eye, (µ1−λ1ko) is the eigenvalue ξ1 associated to the eigenvector ~ψ1 = (1, 0, 0), and the
condition ξ1 = 0 yields again the same condition λ1 = µ1/ko, thus defining the threshold of the classical SIS model. Regarding
the other two eigenvalues ξ2 and ξ3, the result is more cumbersome. Despite of that, the vanishing of the 2x2 determinant of the
right-inferior corner of the Jacobian matrix A4 yields:
λ2 = λ
c
2ii =
λ1ko
lo
η2µ2((β
a
1 (λ1ko − µ1) + µ2) + η1µ1µ2
µ1(η1µ1 + η2µ2) + (λ1ko − µ1)(βa1βa2βb2(λ1ko − µ1) + βa2βb2µ2 + η1µ1βa2 + βa1βb2µ1)
, (A5)
to which the general expression presented in the main text for the epidemic threshold reduces when P (k, l) = δ(k−ko)δ(l− lo).
The agreement between numerical simulations and the analytic expression of the threshold presented here is only accurate when
λ1ko ' µ1, and the reason is easily understandable. Let us compare the reaction of the system to the introduction of a small
seed of SI individuals when both diseases are absent ((IS, SI, II) = (0, 0, 0), case 1) or when the first disease was already
installed in the system ((IS, SI, II) = (pi1, 0, 0), case 2). As we have argued in the precedent sections, the epidemic threshold
is different in each case, and the reason is simply the presence, in the second case, of a fraction pi1 of IS of individuals for which
the infectiousness and recovery rates for disease 2 are different with respect to the rest of individuals. As a consequence, the
mean values of the dynamical parameters averaged over the whole population 〈λ2〉 and 〈µ2〉, are different in both cases and will
yield different values for the epidemic thresholds. Thus, in order to accurately evaluate the secondary threshold for disease 2 it is
essential to know with enough precision the prevalence pi1 corresponding to a single SIS model, as a function of λ1. The problem
arises from the fact that, precisely, the derivation of A5 explicitly assumes that the bijection between pi1 and λ1 is governed by
the mean field stationary expression A2 which is only precise when λ1ko ' µ1 [25]. In fact, a way to rebuild a more accurate
secondary threshold curve can be achieved if, from equation A2 we substitute λ1 as a function of pi1, and then introduce the so
obtained expression into A5 to get:
λc2ii(pi1) =
1
lo
η2µ2(β
a
1
µ1pi1
(1−pi1) + µ2) + η1µ1µ2
(1− pi1)(η1µ1 + η2µ2) + pi1(βa1βa2βb2 µ1pi1(1−pi1) + βa2βb2µ2 + η1µ1βa2 + βa1βb2µ1)
(A6)
which allows to evaluate directly the threshold as a function of pi1 rather than of λ1. Thus, by introducing in equation A6 the pi1
values obtained from the simulations instead of the theoretical prediction of the mean field (equation A2), we recover the curves
for the secondary threshold represented with red lines in Figures 2 and 3 of the main text, in quantitative agreement with results
from simulations.
Obviously, the same arguments stand for the secondary threshold of the first disease, which obeys the following expression:
18
λc1ii(pi2) =
1
ko
η1µ1(β
a
2
µ2pi2
(1−pi2) + µ1) + η2µ2µ1
(1− pi2)(η2µ2 + η1µ1) + pi2(βa2βa1βb1 µ2pi2(1−pi2) + βa1βb1µ1 + η2µ2βa1 + βa2βb1µ2)
(A7)
When the networks are heterogeneous, this reformulation of the threshold curves as a function of pi1 or pi2 can not be done
straightforwardly as no analytical bijection λ1(pi1) or λ2(pi2) can be reached. The best we can do is to use a numerically built-up
relationship λ1(θ1) (or λ2(θ2)), and introduce it into the general expression for the threshold. Although the accuracy of the
curves for the secondary threshold is very satisfactory in Fig. 4, we identify this effect to be the source of the slight divergence
between the analytical and numerical secondary thresholds shown in Fig. 6.
Appendix B: Vanishing conditions for epidemic thresholds
Here we provide a systematic analysis of the behavior of the secondary threshold in our model for large scale-free networks.
In particular, we inspect whether the coupling between the spreading of the two diseases in the terms described in our model can
modify the classical, single-disease scheme, and, if so, under what conditions. The epidemic threshold for the first disease in our
model reads as:
λc1(σ2) = µ1
〈k〉∑
k,l P (k, l)
k2l2σ22β
a
2β
a
1β
b
1+lk
2σ2(η2µ2βa1 +β
b
1(β
a
1µ1+β
a
2µ2))+k
2µ2(η1µ1+η2µ2)
l2σ22β
a
2 η1+lσ2(η1µ1+η2µ2+β
a
2 η1µ2)+µ2(η1µ1+η2µ2)
(B1)
and we have to address its behavior in the limit N →∞. Substituting sums by integrals in Eq. (B1), one gets:
lim
N→∞
λc1(σ2) = lim
(kmax,lmax)→∞
µ1
∫ kmax
kmin
∫ lmax
lmin
P (k, l)k dk dl∫ kmax
kmin
∫ lmax
lmin
P (k, l)
k2l2σ22β
a
2β
a
1β
b
1+lk
2σ2(η2µ2βa1 +β
b
1(β
a
1µ1+β
a
2µ2))+k
2µ2(η1µ1+η2µ2)
l2σ22β
a
2 η1+lσ2(η1µ1+η2µ2+β
a
2 η1µ2)+µ2(η1µ1+η2µ2)
dk dl
.
(B2)
To study the behavior of the threshold in the thermodynamic limit, we present here an analysis which is essentially based on
the following result, whose proof is an exercise of elementary algebra that we present for the sake of completeness in the last
appendix. Given two polynomials P (k), Q(k), we have that:∣∣∣∣∣ limkmax→∞
∫ kmax
kmin
P (k)
Q(k)
dk
∣∣∣∣∣ =∞↔ deg(Q)− deg(P ) ≤ 1 (B3)
Focusing on scale-free connectivity distributions, we will distinguish two different scenarios in this section: uncorrelated and
totally correlated layers. In the first case, both networks present a scale free distribution in which the connectivity of a node in a
layer is essentially independent of its degree on the other layer, in such a way that the composed connectivity distribution verifies
P (k, l) = Cok
−γ l−Γ. Instead, in the second case, although both layers are also scale free networks, the degree of any given
node in both layers is forced to be the same. Therefore, nodes which are hubs in a layer are so in the other, and the composed
degree distribution is P (k, l) = Coδ(k− l)k−γ . In addition, we assume that both γ and Γ exponents are rational, hence, we can
write γ = w/x and Γ = y/z with (w, x, y, z) ∈ N. By addressing these two opposite scenarios, our aim is to characterize the
difference, in terms of the spreading dynamics, between the coupling of two diseases that spread by independent means –which
will give place to different networks of contacts– and the coupling of two related diseases –or variations of the same disease–
that spread following the very same mechanisms and, thus, they do so over highly correlated networks of contacts.
1. Uncorrelated scale free layers
If we substitute P (k, l) = Cok−γ l−Γ into eq. B2, we can factorize the double integrals into independent terms:
lim
N→∞
λc1(σ2) = lim
(kmax,lmax)→∞
µ1
∫ kmax
kmin
k1−γdk
∫ lmax
lmin
l−Γdl∫ kmax
kmin
k2−γdk
∫ lmax
lmin
l2σ22β
a
2β
a
1β
b
1+lσ2(η2µ2β
a
1 +β
b
1(β
a
1µ1+β
a
2µ2))+µ2(η1µ1+η2µ2)
lΓ(l2σ22βa2 η1+lσ2(η1µ1+η2µ2+βa2 η1µ2)+µ2(η1µ1+η2µ2))
dl
(B4)
The condition for the numerator to diverge is γ ≤ 2∨Γ ≤ 1. These conditions are verified by networks whose mean connectivity
diverges in the thermodynamic limit. For this reason, networks with those small exponents neither are reasonable systems to
19
TABLE V: Divergence conditions for D2(m) for disease 1. Case 1: uncorrelated scale free layers P (k, l) = Cok−γ l−Γ, γ = (w/x),
Γ = (y/z).
(βa1 , β
b
1, β
a
2 )
parameters
deg(Q)− deg(P )
in D2(m) = P (m)/Q(m)
Divergence condition
(βa1 , β
b
1, β
a
2 )
(βa1 , β
b
1, 0)
(βa1 , 0, 0)
y − z + 1 γ ≤ 3 ∨ Γ ≤ 1
(0, βb1, β
a
2 )
(βa1 , 0, β
a
2 )
(0, βb1, 0)
(0, 0, 0)
y + 1 γ ≤ 3 ∨ Γ ≤ 0
(0, 0, βa2 ) y + z + 1 γ ≤ 3 ∨ Γ ≤ −1
be used to describe any information diffusion process over them nor are found in real systems. Taking this into account, we
will restrict our analysis to the more epidemiologically relevant scenario in which γ > 2 and Γ > 2, although our reasoning is
generalizable to any value of the exponents.
Thus, in the scenario γ > 2 and Γ > 2, the numerator remains always finite and the only phenomenon of interest that could
be found is an eventual vanishing of the threshold due to a divergence in the denominator –D(k, l) in what follows–. D(k, l)
can be factorized to give D(k, l) = D1(k)D2(l), as it can be seen from Eq. B4. The integral in k, D1(k) will diverge if and
only if γ ≤ 3, but the integral in l, D2(l), might independently diverge under some conditions. That situation would suppose the
vanishing of the threshold of the first disease as a consequence of its coupling to the second rather than to internal, dynamical or
topological features. To find out the conditions for D2(l), lets make the following change of variable:
m = l1/z (B5)
so as to change the dependence of the denominator D(k, l) = D1(k)D2(l) in Eq. B4 to D(k,m) = D1(k)D2(m):
lim
N→∞
λc1(σ2) = lim
(kmax,lmax)→∞
µ1
∫ kmax
kmin
k1−γdk∫ kmax
kmin
k2−γdk
∫ l1/zmax
l
1/z
min
(m2zσ22βa2βa1βb1+mzσ2(η2µ2βa1 +βb1(βa1µ1+βa2µ2))+µ2(η1µ1+η2µ2))zmz−1
my(m2zσ22βa2 η1+mzσ2(η1µ1+η2µ2+βa2 η1µ2)+µ2(η1µ1+η2µ2))
dm
(B6)
The last expression has the advantage that the argument of the integral in m, D2(m) is just the quotient of two polynomials,
and thus, its behavior in the limit lmax → ∞ is governed by Eq. (B3) and depends only on the difference of degrees of the
denominator and the numerator. If
D2(m) =
∫ l1/zmax
l
1/z
min
(
m2zσ22β
a
2β
a
1β
b
1 +m
zσ2(η2µ2β
a
1 + β
b
1(β
a
1µ1 + β
a
2µ2)) + µ2(η1µ1 + η2µ2)
)
zmz−1
my (m2zσ22β
a
2η1 +m
zσ2(η1µ1 + η2µ2 + βa2η1µ2) + µ2(η1µ1 + η2µ2))
dm =
∫ l1/zmax
l
1/z
min
P (m)
Q(m)
dm
(B7)
we have that –in the general case in which none of the β and η parameters vanishes– deg(Q)− deg(P ) = 1 + y− z, and hence,
the conditions for D2(m) to diverge are
lim
(kmax,lmax)→∞
∫ l1/zmax
l
1/z
min
P (m)
Q(m)
dm =∞↔ y − z + 1 ≤ 1↔ Γ = y/z ≤ 1 (B8)
Therefore, in the region of interest γ > 2∧Γ > 2, the factorD2(m) can not diverge and make the threshold vanishes. It is worth
noticing that the condition Γ < 1 does not guarantee the vanishing of the threshold, as it also makes the numerator to diverge.
Expression B8 is valid for the case in which none of the β and η parameters of the model vanishes. If this is not the case, i.e., if
some of the infectiousness variations β do vanish −the rest of the parameters can not do that within a realistic epidemiological
framework−, the degrees of the numerator and the denominator in Eq. B7 could vary. In table V we systematically address all
possible combinations of null parameters, and the composed conditions yielding a vanishing threshold for each case.
Once again, we see that, whatever the interacting scheme between both diseases is, the denominator remains always finite
provided that Γ > 2. In conclusion, if no degree correlation is introduced between layers, and for realistic systems characterized
by double power laws verifying γ > 2∧Γ > 2, the behavior of the thresholds in the thermodynamic limit is essentially the same
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TABLE VI: Divergence conditions forD2(m) for disease 1. Case 2: totally correlated scale free layers P (k, l) = Coδ(k−l)k−γ , γ = (w/x).
(βa1 , β
b
1, β
a
2 )
parameters
deg(Q)− deg(P )
in D2(m) = P (m)/Q(m)
Divergence condition
(βa1 , β
b
1, β
a
2 )
(βa1 , β
b
1, 0)
(βa1 , 0, 0)
w − 3x+ 1 γ ≤ 3
(0, βb1, β
a
2 )
(βa1 , 0, β
a
2 )
(0, βb1, 0)
(0, 0, 0)
w − 2x+ 1 γ ≤ 2
(0, 0, βa2 ) w − x+ 1 γ ≤ 1
of the uncoupled systems: the threshold associated to the first disease vanishes if and only if the exponent of its own network
verifies γ ≤ 3, whatever the exponent of the second network. The coupling will introduce, in general, only a finite pre-factor.
The symmetric situation obviously stands for the threshold of the second disease.
2. Totally correlated scale free layers
If we consider the case in which P (k, l) = Coδ(k − l)k−γ , where γ = w/x with (w, x) ∈ N, the epidemic threshold reads
as:
lim
N→∞
λc1(σ2) = lim
(kmax,lmax)→∞
µ1
∫ kmax
kmin
k1−γdk∫ kmax
kmin
k2σ22β
a
2β
a
1β
b
1+kσ2(η2µ2β
a
1 +β
b
1(β
a
1µ1+β
a
2µ2))+µ2(η1µ1+η2µ2)
kγ−2(k2σ22βa2 η1+kσ2(η1µ1+η2µ2+βa2 η1µ2)+µ2(η1µ1+η2µ2))
dk
(B9)
hence, we do not recover the factorization of the denominator previously observed. Instead, after changing the variable to
m = k1/x, we get the following expression:
lim
N→∞
λc1(σ2) = lim
(kmax)→∞
µ1
∫ kmax
kmin
k1−γdk∫ k1/xmax
k
1/x
min
(m2xσ22βa2βa1βb1+mxσ2(η2µ2βa1 +βb1(βa1µ1+βa2µ2))+µ2(η1µ1+η2µ2))xmx−1
mw−2x(m2xσ22βa2 η1+mxσ2(η1µ1+η2µ2+βa2 η1µ2)+µ2(η1µ1+η2µ2))
dm
(B10)
In this expression, the numerator diverges for γ ≤ 2. In turn, the denominator:
D(m) =
∫ k1/xmax
k
1/x
min
(
m2xσ22β
a
2β
a
1β
b
1 +m
xσ2(η2µ2β
a
1 + β
b
1(β
a
1µ1 + β
a
2µ2)) + µ2(η1µ1 + η2µ2)
)
xmx−1
mw−2x (m2xσ22β
a
2η1 +m
xσ2(η1µ1 + η2µ2 + βa2η1µ2) + µ2(η1µ1 + η2µ2))
dm =
∫ k1/xmax
k
1/x
min
P (m)
Q(m)
dm
(B11)
diverges, according to equation B3, if and only if deg(Q)− deg(P ) ≤ 1. In the general case in which none of the β parameters
vanishes, we have that deg(Q)− deg(P ) = w − 3x+ 1, and thus:
lim
N→∞
λc1(σ2) = 0↔ γ ≤ 3 (B12)
As in the previous case, different combinations of null β parameters can change this result, as it can be seen in Table VI. Here,
the phenomenology is remarkable different for all the cases in which at least one of the two variations of disease 1 infectiousness,
βa1 or β
b
1, cancel (except for the case β
a
2 = β
b
1 = 0 but β
a
1 6= 0, for which eq. B12 also stands). In those cases, θ > 0 guarantees
that, provided that γ > 2, no threshold vanishing is observed in the thermodynamic limit, even when the exponent is within the
interval 2 < γ ≤ 3. In the case in which βa1 = βb1 = βa2 = 0, the situation will be reciprocal, and thus, the epidemic threshold
of the second disease will not vanish either for γ > 2.
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Appendix C: Proof of eq. B3
Given two polynomials P (k), Q(k), we have to prove that∣∣∣∣∣ limkmax→∞
∫ kmax
kmin
P (k)
Q(k)
dk
∣∣∣∣∣ =∞↔ deg(Q)− deg(P ) ≤ 1 (C1)
First, we have that, if deg(P ) ≥ deg(Q) the integral diverges, as the argument of the integral can be expressed in that case as:
P (k)
Q(k)
= C(k) +
P ′(k)
Q′(k)
(C2)
with deg(P ′) < deg(Q′) and deg(C) ≥ 0. When substituting the last expression into eq.B3, the integral in C(k) automatically
diverges. Therefore, to prove this result for the case in which deg(P ) < deg(Q), let us consider the general decomposition of
Q(k):
Q(k) = Qo
i∗∏
i=1
(k − ai)ni
j∗∏
j=1
(k2 + bjk + cj)
mj (C3)
where Qo is a constant, kmin > 0 and b2j − 4cj < 0 ∀j. The values i∗ and j∗ stand for the number of different elemental factors
of first and second order, respectively. So, the degree of the polynomial reads as follows:
deg(Q) =
i∗∑
i=1
ni + 2
j∗∑
j=1
mj , (C4)
where ni and mj denote the multiplicity of each of the factors of first and second order, respectively. The factorization of Q(k)
yields the following decomposition of the quotient P (k)/Q(k) into partial fractions:
∫ kmax
kmin
P (k)
Q(k)
dk =
i∗∑
i=1
ni∑
n=1
∫ kmax
kmin
Ai,n
(k + ai)n
dk +
j∗∑
j=1
mj∑
m=1
∫ kmax
kmin
Bj,mk + Cj,m
(k2 + bjk + cj)m
dk (C5)
where the coefficients Ai,n, Bj,m, Cj,m have to be calculated by expanding this expression into a single fraction, and comparing
the coefficients of the numerator obtained with those of P ′(k) = P (k)/Qo. With the aim of understanding what are the
conditions that make these partial integrals to diverge, let us analyze them term by term. The first sum yields logarithmic and
rational functions:
i∗∑
i=1
ni∑
n=1
∫ kmax
kmin
Ai,n
(k + ai)n
dk =
i∗∑
i=1
Ai,1 ln
(
kmax + ai
kmin + ai
)
+
i∗∑
i=1|ni>1
ni∑
n=2
−Ai,n
(n− 1)
(
1
(kmin + ai)n−1
− 1
(kmax + ai)n−1
)
(C6)
and, in the limit kmax →∞, only the logarithmic term diverges:
lim
kmax→∞
i∗∑
i=1
ni∑
n=1
∫ kmax
kmin
Ai,n
(k + ai)n
dk =
i∗∑
i=1
Ai,1 ln (kmax) + ϑ (C7)
where ϑ stands for a finite term, negligible when compared to ln(kmax). On the other hand, the second sum in eq. C5 can be
rewritten as:
j∗∑
j=1
mj∑
m=1
∫ kmax
kmin
Bj,mk + Cj,m
(k2 + bjk + cj)m
dk =
j∗∑
j=1
mj∑
m=1
Bj,m
2
∫ kmax
kmin
2k + bj
(k2 + bjk + cj)m
dk +
(
Cj,m −
Bj,m
2
)∫ kmax
kmin
dk
(k2 + bjk + cj)m
dk (C8)
In turn, the integrals in the first sum of eq. C8 can be easily solved:∑j∗
j=1
∑mj
m=1
Bj,m
2
∫ kmax
kmin
2k+bj
(k2+bjk+cj)m
dk =
∑j∗
j=1
Bj,m
2 ln
(k2max+bjkmax+cj)
(k2min+bjkmin+cj)
+
+
∑j∗
j=1|mj>1
∑mj
m=1
Bj,m
2
(
1
k2min+bjkmin+cj
− 1k2max+bjkmax+cj
) (C9)
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and, again, when taking the limit kmax →∞, only the logarithmic terms diverge:
j∗∑
j=1
mj∑
m=1
Bj,m
2
∫ kmax
kmin
2k + bj
(k2 + bjk + cj)m
dk =
j∗∑
j=1
Bj,m
2
ln (k2max) + ϑ =
j∗∑
j=1
Bj,m ln (kmax) + ϑ (C10)
Finally, we have to analyze the last integrals in eq. C8. After the following linear transformation:
v =
2k + bj√
4cj − b2j
(C11)
we can rewrite:(
Cj,m − Bj,m
2
)∫ kmax
kmin
dk
(k2 + bjk + cj)m
=
(
Cj,m − Bj,m
2
)(
cj −
(
bj
2
)2)1/2−m ∫ 2kmax+bj√
4cj−b2j
2kmin+bj√
4cj−b2j
1
(v2 + 1)m
dv (C12)
and, though it is not possible to write an explicit solution for the integrals of the form
∫
1/(v2 + 1)m, integrating by parts we
get: ∫
1
(v2 + 1)m
dv =
v
(2m− 2)(v2 + 1)m−1 +
2m− 3
2m− 2
∫
dv
(v2 + 1)m−1
(C13)
which allows to solve the integrals, yielding the appearance of rational and arctangent terms none of which diverges in the limit
kmax →∞. Thus, only logarithmic terms from equations C7 and C10 contribute to the divergence of the initial limit of Eq. B3,
that can be finally rewritten as follows:∣∣∣∣∣ limkmax→∞
∫ kmax
kmin
P (k)
Q(k)
dk
∣∣∣∣∣ = ln (kmax)
∣∣∣∣∣∣
i∗∑
i=1
Ai,1 +
j∗∑
j=1
Bj,m
∣∣∣∣∣∣+ ϑ (C14)
Thus, recalling that |ϑ| << ln(kmax) stands for finite terms, the only requisite for the limit to diverge is that: i∗∑
i=1
Ai,1 +
j∗∑
j=1
Bj,m
 6= 0 (C15)
which is precisely the coefficient of the monomial of degree equal to deg(Q) − 1 in the numerator P ′(k) = P (k)/Qo, as can
be easily shown after grouping the partial fractions in Eq. C5 into a single one. Therefore, we have demonstrated the initial
statement: the condition for the integral in Eq. (C1) to diverge is that deg(P ′) = deg(P ) ≥ deg(Q)− 1.
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